Steven Kafka, PhD

President and Chief Operating Officer

Dr. Kafka joined Foundation Medicine in January 2013, bringing over 15 years of business and strategy experience in the pharmaceutical and biotechnology industries, with a focus on targeted therapies in oncology. Dr. Kafka was previously chief operating officer and chief financial officer at Aileron Therapeutics, where he led the company’s operations, finance, and human resources functions.

Before this, Dr. Kafka was vice president of finance at Infinity Pharmaceuticals (NASDAQ: INFI) where he led finance, investor and public relations and business operations. While at Infinity, he worked on a number of innovative collaborations with leading pharmaceutical companies, including the company’s strategic alliance with Purdue Pharmaceuticals. Earlier in his career, Dr. Kafka was senior director of finance at Millennium Pharmaceuticals, where he was a key member of the product team in driving strategic planning and alliance management efforts with partner Johnson & Johnson for VELCADE®, a novel targeted cancer therapeutic.

Dr. Kafka earned his Ph.D. from Harvard University and his B.A. with Distinction and Honors from Stanford University.